Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Pfizer initiates clinical trial in panic disorder

March 12, 1997

Bayer claims potassium channel modulators

March 12, 1997

Cytogen seeks Canadian approval for Quadramet

March 11, 1997

Painless local dermal anesthesia now available

March 11, 1997

Eurand develops taste-masked form of ketoprofen

March 11, 1997

Novo Nordisk characterizes potential antipsychotic agent

March 11, 1997

Preclinical toxicity, pharmacokinetics and metabolism of SM-9018 described

March 10, 1997

Agents for CNS disorders described by American Home Products

March 10, 1997

Vyrex and Immune Response form collaboration

March 7, 1997

AIT-082 enters clinic

March 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...